William Hoffman - 07 Feb 2022 Form 4 Insider Report for Inari Medical, Inc.

Signature
/s/ Angela Ahmad, attorney-in-fact for William Hoffman
Issuer symbol
N/A
Transactions as of
07 Feb 2022
Net transactions value
-$2,207,555
Form type
4
Filing time
09 Feb 2022, 18:57:15 UTC
Previous filing
09 Feb 2022
Next filing
22 Feb 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NARI Common Stock Options Exercise $12,840 +30,000 +5.6% $0.4280* 566,867 07 Feb 2022 Direct F1
transaction NARI Common Stock Sale $28,649 -400 -0.07% $71.62 568,287 07 Feb 2022 Direct F1, F2
transaction NARI Common Stock Sale $466,874 -6,367 -1.1% $73.33 561,920 07 Feb 2022 Direct F1, F3
transaction NARI Common Stock Sale $1,548,132 -20,870 -3.7% $74.18 541,050 07 Feb 2022 Direct F1, F4
transaction NARI Common Stock Sale $176,740 -2,363 -0.44% $74.79 538,687 07 Feb 2022 Direct F1, F5, F6

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NARI Stock Options (Right to buy) Options Exercise $0 -30,000 -13% $0.000000 200,467 07 Feb 2022 Common Stock 30,000 $0.4280 Direct F1, F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 16, 2021.
F2 This transaction was executed in multiple trades at prices ranging from $71.43 to $72.2050. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F3 This transaction was executed in multiple trades at prices ranging from $72.71 to $73.70. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F4 This transaction was executed in multiple trades at prices ranging from $73.7250 to $74.68. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F5 This transaction was executed in multiple trades at prices ranging from $74.74 to $74.97. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F6 Includes 69 shares acquired under the Employee Stock Purchase Plan on January 31, 2022.
F7 Option vested with respect to 25% of the underline shares on May 3, 2019 and vest with respect to the remaining shares in 36 equal monthly installments thereafter.